Genus plc (LON:GNS – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 2,569.03 and traded as low as GBX 2,060. Genus shares last traded at GBX 2,079.90, with a volume of 286,615 shares trading hands.
Wall Street Analyst Weigh In
Separately, Berenberg Bank restated a “buy” rating and issued a GBX 3,350 price target on shares of Genus in a research report on Monday, May 11th. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of GBX 3,216.67.
Check Out Our Latest Stock Report on Genus
Genus Stock Performance
Insider Buying and Selling at Genus
In other news, insider Celia Baxter bought 2,336 shares of the firm’s stock in a transaction that occurred on Friday, June 26th. The stock was acquired at an average cost of GBX 2,140 per share, with a total value of £49,990.40. Also, insider Jorgen Kokke sold 3,450 shares of the company’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of GBX 2,267, for a total value of £78,211.50. Insiders own 0.71% of the company’s stock.
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Featured Articles
- Five stocks we like better than Genus
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
